Professional Marketing briefs

Share this article:
Cegedim Dendrite will deploy a new customer help-desk tool to clients worldwide. Amdocs' Smart Agent Desktop, will automate current processes so that pharma clients receive global reports that help them pinpoint worldwide support issues.

Eisai received a DDMAC warning letter for a Dacogen patient-profile card, a sales aid used when detailing physicians. DDMAC said the card was misleading, because it minimizes risks, overstates efficacy and omits material facts.

Celgene is poised to bring Istodax to market after acquiring the firm that oversaw development, Gloucester Pharmaceuticals. An early 2010 launch is planned for the lymphoma drug.

A recommendation issued by the New Jersey Division of Consumer Affairs calls for a new Board of Medical Examiners rule requiring that 25% of licensed physicians' CME be obtained in evidence-based educational programs or academic detailing.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.